Rapamycin, a well-known mammalian target of rapamycin (mTOR) inhibitor, has demonstrated considerable anti-cancer potential, particularly in inhibiting tumor cell proliferation, blocking angiogenesis, and inducing autophagy [7]. This evidence concerns the gene MTOR and cancer.